Lots More Information

Resources

References

Wilt T, Ishani A, MacDonald R, Stark G, Mulrow C, Lau J. Beta-sitosterols for Benign Prostatic Hyperplasia (Cochrane Review). Chichester, UD: John Wiley & Sons, Ltd.; Issue 3, 2006.

Huang HY, Caballero B, Chang S, et al.The efficacy and safety of multivitamin and mineral supplement use to prevent cancer and chronic disease in adults: A systematic review for a National Institutes of Health State-of-the-Science Conference. Ann Intern Med. 2006 Jul 31; [Epub ahead of print]

Bairati I, Meyer F, Gelinas M, et al. Randomized trial of antioxidant vitamins to prevent acute adverse effects of radiation therapy in head and neck cancer patients. J Clin Oncol. 2005 Aug 20;23(24):5455-7.

Borek C. Dietary Antioxidants and Human Cancer. Integrative Cancer Therapies. 2004 3: 333-341.

Prasad KN. Multiple Dietary Antioxidants Enhance the Efficacy of Standard and Experimental Cancer Therapies and Decrease Their Toxicity. Integrative Cancer Therapies. 2004 3: 310-322.

Li, H, Kantoff PW, Giovannucci P et al. Manganese Superoxide Dismutase Polymorphism, Prediagnostic Antioxidant Status, and Risk of Clinical Significant Prostate Cancer. Cancer Research. 2005;65: 2498-2504.

Villa P. L-folic acid supplementation in healthy postmenopausal women: effect on homocysteine and glycolipid metabolism. J Clin Endocrinol Metab. 2005; 90(8): 4622-9.

Duffield-Lillico AJ, Reid ME, Turnull BW, et al. Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: A summary report of the Nutritional Prevention of Cancer Trial. Cancer Epid Biomarkers. Prev 11:630-639, 2002.

Heinonen OP, Albanes D, Huttunen JK, et al. Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial. J. Natl Cancer Inst. 90:440-6, 1998.

Corrada MM, Kawas CH, Hallfrisch J, Muller D, Brookmeyer R.Reduced risk of Alzheimer’s disease with high folate intake: The Baltimore Longitudinal Study of Aging. Alzheimer's & Dementia: The Journal of the Alzheimer's Association. 2005;1:11-18.

Miller ER 3rd, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LA, Guallar E. Meta-analysis: High-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med. 2005;142:37-46.

Levy AP, Gerstein HC, Miller-Lotan R, Ratner R, McQueen M, Lonn E, Pogue J. The Effect of Vitamin E Supplementation on Cardiovascular Risk in Diabetic Individuals With Different Haptoglobin Phenotypes. Diabetes Care. 2004 27: 2767.

Lonn E, Bosch J, Yusef S, et al. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial.JAMA. 2005;293:1338-1347.

Etminan M, Gill SS, Samii A. Intake of vitamin E, vitamin C, and carotenoids and the risk of Parkinson's disease: a meta-analysis Lancet Neurol.2005; 4(6): 362-5.

The HOPE and HOPE-TOO Trial Investigators. Effects of Long-term vitamin E supplementation on cardiovascular events and cancer: A randomized controlled trial. JAMA. 293:1138-1347, 2005.

Clark L.C., Combs GF Jr, Turnbull B.W., et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA. 276:1957-1963, 1996.

Duffield-Lillico AJ, Reid ME, Turnull BW, et al. Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: A summary report of the Nutritional Prevention of Cancer Trial. Cancer Epid Biomarkers. Prev 11:630-639, 2002.

Heinonen OP, Albanes D, Huttunen JK, et al. Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial. J. Natl Cancer Inst. 90:440-6, 1998.

Weinstein SJ, Wright ME, Pietinen P, et al. Serum alpha-tocopherol and gamma-tocopherol in relation to prostate cancer risk in a prospective study. J Natl Cancer Inst. 97:396-399, 2005.

The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med. 342: 145-153, 2000.

The Heart Outcomes Prevention Evaluation Study Investigators. Vitamin E supplementation and cardiovascular events in high-risk patients. N Engl J Med. 342: 154-160, 2000.

John F. Aloia, MD; Sonia Arunabh Talwar, MD; Simcha Pollack, PhD; James Yeh, PhD. A Randomized Controlled Trial of Vitamin D3 Supplementation in African American Women. Arch Intern Med. 2005; 165: 1618 – 1623.

Bertone-Johnson ER Hankinson SE, Bendich A, Johnson SR, Willett WC, Manson JE. and vitamin D intake and risk of incident premenstrual syndrome. Arch Intern Med. 2005; 165:1246-1252.

Miller ER 3rd, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LA, Guallar E. Meta-analysis: High-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med. 2005;142:37-46.

Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342:154-60.

McNeil JJ, Robman L, Tikellis G, Sinclair MI, McCarty CA, Taylor HR. Vitamin E supplementation and cataract: randomized controlled trial. Ophthalmology. 2004;111:75-84.

Lonn E, Bosch J, Yusef S, et al. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial.JAMA. 2005;293:1338-1347.

Bagchi D, Sen CK, Bagchi M, Atalay M. Anti-angiogenic, antioxidant, and anti-carcinogenic properties of a novel anthocyanin-rich berry extract formula.Biochemistry (Mosc). 2004;69(1):75-80, 1 p preceding 75.

Roy S, Khanna S, Alessio HM, Vider J, Bagchi D, Bagchi M, Sen CK. Anti-angiogenic property of edible berries.Free Radic Res. 2002 Sep;36(9):1023-31.

Blodi BA, Nutritional supplements in the prevention of age-related macular degeneration. Insight. 2004 Jan-Mar;29(1):15-6; quiz 17-8.

Head KA, Natural therapies for ocular disorders, part two: cataracts and glaucoma. Altern Med Rev. 2001 Apr;6(2):141-66.